Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
What Analyst Projections for Key Metrics Reveal About Gilead (GILD) Q1 Earnings
10:20am, Friday, 18'th Apr 2025
Evaluate the expected performance of Gilead (GILD) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for
Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?
02:10pm, Thursday, 17'th Apr 2025
Gilead Sciences' leading HIV business might face a slowdown in 2025, even though a potential approval of lenacapavir would be a significant boost. We recommend investors to wait and watch for now.
Gilead Sciences (GILD) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Thursday, 17'th Apr 2025
Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?
02:05pm, Wednesday, 16'th Apr 2025
At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV prevention, and recent positive estimate revisions.
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
10:05am, Wednesday, 16'th Apr 2025
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025
04:05pm, Thursday, 10'th Apr 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2025 financial results and guidance will be released on Thursday, April 24
Gilead Sciences (GILD) Increases Yet Falls Behind Market: What Investors Need to Know
06:50pm, Wednesday, 09'th Apr 2025
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $105.25, denoting a +2% change from the preceding trading day.
Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Wednesday, 09'th Apr 2025
Gilead (GILD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Wednesday, 09'th Apr 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
2 Top Dividend Stocks That Could Set You Up for Life
07:00am, Wednesday, 09'th Apr 2025
With equity markets in shambles due to President Donald Trump's trade policies, now might be as good a time as any to invest in excellent dividend stocks.
5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025
02:25pm, Monday, 07'th Apr 2025
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and soli
Is Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic?
10:46am, Monday, 07'th Apr 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
09:30am, Friday, 04'th Apr 2025
Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.
Live Nasdaq Composite: FIVE Falls, AZN and PEP Rise From Tariff Ashes
09:30am, Friday, 04'th Apr 2025
The markets have succumbed to the tariff-fueled selling pressure, and there is nowhere to hide. President Trump’s tariff plan is intensifying the trade war. The Dow Jones Industrial is spiraling
Top 3 Nasdaq 100 stocks rising as it moves into a correction
02:01am, Friday, 04'th Apr 2025
The Nasdaq 100 Index has slumped into a technical correction this year, falling by over 16% from its highest level in January. It has crashed to a low of $18,520, its lowest level since August 9 of la
